Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Actinium Pharmaceuticals in a report released on Tuesday, April 30th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will post earnings of ($1.35) per share for the year, up from their […]
HC Wainwright reiterated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $50.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Actinium Pharmaceuticals’ Q2 2024 earnings at ($0.38) EPS, Q3 2024 earnings at ($0.45) EPS, […]
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Shares Down 7 1% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have been given a consensus recommendation of “Buy” by the five ratings firms that are currently covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 1,850,000 shares, a decrease of 7.5% from the October 31st total of 2,000,000 shares. Based on an average daily volume of 190,100 shares, […]